
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14343007
[patent_doc_number] => 20190153476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => CRISPR-CAS SYSTEMS FOR ALTERING EXPRESSION OF GENE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 16/177403
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16177403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/177403 | CRISPR-CAS SYSTEMS FOR ALTERING EXPRESSION OF GENE PRODUCTS | Oct 30, 2018 | Pending |
Array
(
[id] => 17998067
[patent_doc_number] => 11499163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Expression method of Haemocoagulase Acutus (Halase) recombinant protein
[patent_app_type] => utility
[patent_app_number] => 16/175812
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2487
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175812
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/175812 | Expression method of Haemocoagulase Acutus (Halase) recombinant protein | Oct 29, 2018 | Issued |
Array
(
[id] => 14868665
[patent_doc_number] => 20190284574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => Stable Production of Lentiviral Vectors
[patent_app_type] => utility
[patent_app_number] => 16/166459
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166459
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166459 | Stable Production of Lentiviral Vectors | Oct 21, 2018 | Abandoned |
Array
(
[id] => 19027306
[patent_doc_number] => 11926653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Methods and materials for NT-3 gene therapy
[patent_app_type] => utility
[patent_app_number] => 16/757176
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 10
[patent_no_of_words] => 35710
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757176
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757176 | Methods and materials for NT-3 gene therapy | Oct 18, 2018 | Issued |
Array
(
[id] => 16541297
[patent_doc_number] => 20200407710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS FOR HIGH-RESOLUTION GENOME-WIDE FUNCTIONAL DISSECTION OF TRANSCRIPTIONAL REGULATORY REGIONS
[patent_app_type] => utility
[patent_app_number] => 16/757296
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757296 | Methods for high-resolution genome-wide functional dissection of transcriptional regulatory regions | Oct 16, 2018 | Issued |
Array
(
[id] => 15194279
[patent_doc_number] => 10494621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Crispr enzyme mutations reducing off-target effects
[patent_app_type] => utility
[patent_app_number] => 16/158295
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 71
[patent_no_of_words] => 249830
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16158295
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/158295 | Crispr enzyme mutations reducing off-target effects | Oct 10, 2018 | Issued |
Array
(
[id] => 14808869
[patent_doc_number] => 20190271044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHODS FOR SEQUENCING SAMPLES
[patent_app_type] => utility
[patent_app_number] => 16/154307
[patent_app_country] => US
[patent_app_date] => 2018-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16154307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/154307 | Methods for sequencing samples | Oct 7, 2018 | Issued |
Array
(
[id] => 17587954
[patent_doc_number] => 11326212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Biomarkers for non-hodgkin lymphomas and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/148576
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 6
[patent_no_of_words] => 24920
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148576 | Biomarkers for non-hodgkin lymphomas and uses thereof | Sep 30, 2018 | Issued |
Array
(
[id] => 14185327
[patent_doc_number] => 20190112368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/138180
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138180
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138180 | Methods of producing two chain proteins in bacteria | Sep 20, 2018 | Issued |
Array
(
[id] => 13734003
[patent_doc_number] => 20180371469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => EXPRESSION CONSTRUCTS AND METHODS OF GENETICALLY ENGINEERING METHYLOTROPHIC YEAST
[patent_app_type] => utility
[patent_app_number] => 16/123121
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123121 | Expression constructs and methods of genetically engineering methylotrophic yeast | Sep 5, 2018 | Issued |
Array
(
[id] => 18084310
[patent_doc_number] => 11534417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Enhanced expression of RNA vectors
[patent_app_type] => utility
[patent_app_number] => 16/122376
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 12408
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/122376 | Enhanced expression of RNA vectors | Sep 4, 2018 | Issued |
Array
(
[id] => 17875742
[patent_doc_number] => 11447745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => End-to-end cell therapy automation
[patent_app_type] => utility
[patent_app_number] => 16/119618
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 60
[patent_no_of_words] => 32338
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16119618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/119618 | End-to-end cell therapy automation | Aug 30, 2018 | Issued |
Array
(
[id] => 18399462
[patent_doc_number] => 11661589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Compositions and methods for controlling microbial growth
[patent_app_type] => utility
[patent_app_number] => 16/113671
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 25
[patent_no_of_words] => 16754
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16113671
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/113671 | Compositions and methods for controlling microbial growth | Aug 26, 2018 | Issued |
Array
(
[id] => 13958453
[patent_doc_number] => 20190055570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => E. coli Separatome-Based Protein Expression And Purification Platform
[patent_app_type] => utility
[patent_app_number] => 16/113840
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16113840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/113840 | E. coli Separatome-Based Protein Expression And Purification Platform | Aug 26, 2018 | Abandoned |
Array
(
[id] => 14343111
[patent_doc_number] => 20190153528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHOD FOR TARGET SPECIFIC RNA TRANSCRIPTION OF DNA SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 16/101083
[patent_app_country] => US
[patent_app_date] => 2018-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16101083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/101083 | Method for target specific RNA transcription of DNA sequences | Aug 9, 2018 | Issued |
Array
(
[id] => 14639419
[patent_doc_number] => 10364442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => CRISPR enabled multiplexed genome engineering
[patent_app_type] => utility
[patent_app_number] => 16/056310
[patent_app_country] => US
[patent_app_date] => 2018-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 25
[patent_no_of_words] => 9498
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16056310
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/056310 | CRISPR enabled multiplexed genome engineering | Aug 5, 2018 | Issued |
Array
(
[id] => 13607501
[patent_doc_number] => 20180355300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => MULTILAYERED CELL CULTURE APPARATUS
[patent_app_type] => utility
[patent_app_number] => 16/054270
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054270
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054270 | MULTILAYERED CELL CULTURE APPARATUS | Aug 2, 2018 | Abandoned |
Array
(
[id] => 15436283
[patent_doc_number] => 20200032325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => SPECIFIC DETECTION OF DEOXYRIBONUCLEIC ACID SEQUENCES USING NOVEL CRISPR ENZYME-MEDIATED DETECTION STRATEGIES
[patent_app_type] => utility
[patent_app_number] => 16/049460
[patent_app_country] => US
[patent_app_date] => 2018-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16049460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/049460 | Specific detection of deoxyribonucleic acid sequences using novel CRISPR enzyme-mediated detection strategies | Jul 29, 2018 | Issued |
Array
(
[id] => 14581987
[patent_doc_number] => 20190218602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/048038
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 207313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16048038
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/048038 | CRISPR enzymes and systems | Jul 26, 2018 | Issued |
Array
(
[id] => 17997855
[patent_doc_number] => 11498949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => System and method for high-yield transient expression in mammalian cells
[patent_app_type] => utility
[patent_app_number] => 16/046641
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 33147
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046641
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/046641 | System and method for high-yield transient expression in mammalian cells | Jul 25, 2018 | Issued |